50 related articles for article (PubMed ID: 232733)
1. [Corneal deposits in children on dialysis and treatment with vitamin D3 and 1,25 DHCC (author's transl)].
Severin M; Bulla M
Klin Monbl Augenheilkd; 1979 Nov; 175(5):670-6. PubMed ID: 232733
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
Bulla M; Delling G; Offermann G; Ziegler R; Benz G; Lühmann H; Sanchez de Reutter A; Severin M
Proc Eur Dial Transplant Assoc; 1979; 16():644-8. PubMed ID: 232917
[TBL] [Abstract][Full Text] [Related]
4. [Corneal changes in patients on dialysis for renal failure (author's transl)].
Severin M; Domarus Dv; Finke K
Klin Monbl Augenheilkd; 1978 May; 172(5):670-7. PubMed ID: 79004
[TBL] [Abstract][Full Text] [Related]
5. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies of calcium resorption modified by vitamin D2 and D3 in patients with chronic renal failure and dialysis patients].
Fünfstück R; Günther K; Tietz U; Brandstädt A; Stein G; Hartwich R
Z Urol Nephrol; 1986 Apr; 79(5):287-94. PubMed ID: 3017021
[TBL] [Abstract][Full Text] [Related]
7. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
8. [Corneal and conjunctival deposits in the eyes of patients treated with periodic haemodialysis. Study of 47 patients (author's transl)].
Michaud PA
Klin Monbl Augenheilkd; 1978 Apr; 172(4):523-6. PubMed ID: 651224
[TBL] [Abstract][Full Text] [Related]
9. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)].
Kovarik J; Graf H; Stummvoll HK; Wolf A; Pinggera W
Wien Klin Wochenschr; 1979 Nov; 91(22):765-8. PubMed ID: 516748
[TBL] [Abstract][Full Text] [Related]
10. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD
Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
[TBL] [Abstract][Full Text] [Related]
11. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
Cremer W; Graben N; Merguet P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
[No Abstract] [Full Text] [Related]
12. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
13. [Vitamin D3 metabolism in renal failure (author's transl)].
Ogura Y
Nihon Naika Gakkai Zasshi; 1978 Jul; 67(7):683-93. PubMed ID: 212493
[No Abstract] [Full Text] [Related]
14. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
15. [Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].
Bulla M; Delling G; Benz-Bohm G; Stock GJ; Sánchez de Reutter A; Ziegler R; Lühmann H; Severin M; Kalbitzer E; Manegold C
Klin Wochenschr; 1980 May; 58(10):511-9. PubMed ID: 7392529
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia in children on renal replacement therapy.
Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
[TBL] [Abstract][Full Text] [Related]
17. [Hypercalcemia in a female patient with chronic kidney failure secondary to sarcoidosis: a metabolic study of the calcium metabolism and bone histology].
Caravaca F; Cubero JJ; de Francisco AL; Arrobas M; Pizarro JL; Sánchez-Casado E
Med Clin (Barc); 1991 May; 96(17):659-61. PubMed ID: 2056801
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure.
Ljutić D; Cameron JS; Ogg CS; Turner C; Hicks JA; Owen WJ
QJM; 1994 Nov; 87(11):685-92. PubMed ID: 7820543
[TBL] [Abstract][Full Text] [Related]
20. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]